Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1986 1
1987 2
1988 1
1989 4
1990 2
1991 5
1992 6
1993 7
1994 4
1995 6
1996 13
1997 3
1998 9
1999 10
2000 20
2001 24
2002 48
2003 56
2004 64
2005 98
2006 111
2007 116
2008 131
2009 145
2010 190
2011 199
2012 287
2013 281
2014 320
2015 398
2016 427
2017 395
2018 474
2019 595
2020 743
2021 843
2022 905
2023 899
2024 301

Text availability

Article attribute

Article type

Publication date

Search Results

7,195 results

Results by year

Filters applied: . Clear all
Page 1
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
Chowdhury S, Kennedy JJ, Ivey RG, Murillo OD, Hosseini N, Song X, Petralia F, Calinawan A, Savage SR, Berry AB, Reva B, Ozbek U, Krek A, Ma W, da Veiga Leprevost F, Ji J, Yoo S, Lin C, Voytovich UJ, Huang Y, Lee SH, Bergan L, Lorentzen TD, Mesri M, Rodriguez H, Hoofnagle AN, Herbert ZT, Nesvizhskii AI, Zhang B, Whiteaker JR, Fenyo D, McKerrow W, Wang J, Schürer SC, Stathias V, Chen XS, Barcellos-Hoff MH, Starr TK, Winterhoff BJ, Nelson AC, Mok SC, Kaufmann SH, Drescher C, Cieslik M, Wang P, Birrer MJ, Paulovich AG. Chowdhury S, et al. Among authors: ji j. Cell. 2023 Aug 3;186(16):3476-3498.e35. doi: 10.1016/j.cell.2023.07.004. Cell. 2023. PMID: 37541199 Free PMC article.
Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.
Wang M, Li W, Tomimatsu N, Yu CH, Ji JH, Alejo S, Witus SR, Alimbetov D, Fitzgerald O, Wu B, Wang Q, Huang Y, Gan Y, Dong F, Kwon Y, Sareddy GR, Curiel TJ, Habib AA, Hromas R, Dos Santos Passos C, Yao T, Ivanov DN, Brzovic PS, Burma S, Klevit RE, Zhao W. Wang M, et al. Among authors: ji jh. Mol Cell. 2023 Oct 19;83(20):3679-3691.e8. doi: 10.1016/j.molcel.2023.09.015. Epub 2023 Oct 4. Mol Cell. 2023. PMID: 37797621
Fractional quantum ferroelectricity.
Ji J, Yu G, Xu C, Xiang HJ. Ji J, et al. Nat Commun. 2024 Jan 2;15(1):135. doi: 10.1038/s41467-023-44453-y. Nat Commun. 2024. PMID: 38167841 Free PMC article.
Differences between migrasome, a 'new organelle', and exosome.
Xu X, Wu T, Lin R, Zhu S, Ji J, Jin D, Huang M, Zheng W, Ni W, Jiang F, Xuan S, Xiao M. Xu X, et al. Among authors: ji j. J Cell Mol Med. 2023 Dec;27(23):3672-3680. doi: 10.1111/jcmm.17942. Epub 2023 Sep 4. J Cell Mol Med. 2023. PMID: 37665060 Free PMC article. Review.
Biomaterials evolution: from inert to instructive.
Iqbal S, Sohail M, Fang S, Ding J, Shen L, Chen M, Shu G, Du YZ, Ji J. Iqbal S, et al. Among authors: ji j. Biomater Sci. 2023 Sep 12;11(18):6109-6115. doi: 10.1039/d3bm00322a. Biomater Sci. 2023. PMID: 37591802 Review.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: ji j. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
7,195 results